supported by the Shanghai Key Medical Specialty Program(China)(No.ZK2019A03 to Y.W.);Natural Science Research Funds of Minhang District,Shanghai,China(No.2021MHZ071 to Y.W.);Scientific Research Project funded by Shanghai Fifth People’s Hospital,Fudan University(No.2020WYZT02 to Y.W.);the National Natural Science Foundation of China(No.82373237 to B.F.,82172644 to W.Q.L);ECNU Multifunctional Platform for Innovation(011);The Instruments Sharing Platform of School of Life Science,East China Normal University.
Myeloid-derived suppressor cells(MDSCs)constitute a crucial component of the immunosuppressive tumor microenvironment.1 Prostaglandin E2 receptor 4(EP4)is involved in regulating immunosuppressive MDSC differentiation ...
supported by the National Natural Science Foundation of China(Grant numbers 81973243,81861148031,81520108020 and 31401130).
p53,a tumor suppressor protein,has a vital role in the regulation of the cell cycle,apoptosis,and DNA damage repair.The degradation of p53 is predominantly controlled by the murine double minute 2(MDM2)protein,a ubiqu...
supported by the National Natural Science Foundation of China(grant Nos.81930096 and 82373830).
MRGPRX2 antagonists possess the potential for the treatment of allergic rhinitis,atopic dermatitis,and chronic urticaria.Previously,we identified a class of diaryl urea(DPU)MRGPRX2 antagonists with sub-micromolar IC50...
Objective To explore the ffects of G protein-coupled receptor 55(GPR55)antagonist CIDI 6020046 on renal fibrosis in mice,and provide a new method and idea for the treatment of renal fibrosis.Methods(1)GPR55 overexpres...
supported by the National Natural Science Foundation of China(Nos.82073765,82273853).
G protein-coupled receptor 91(GPR91)has garnered widespread attention as a prospective therapeutic target for metabolic diseases.However,no structural data for human GPR91(hGPR91);detailed molecular mechanism of actio...
supported by Natural Science Foundation of Guangdong Province(Nos.2021A1515010101,2021A1515011372,2023A1515011895);National Natural Science Foundation of China(Nos.21807017,82273759,32371529);Guangzhou Medical University Scientific Research Capacity Improvement Project(No.02-410-2405104)。
α_(1)-Adrenergic receptor(AR)blockers can be effective for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms(BPH/LUTS),their usage is limited by cardiovascular-related side effects that are c...
the Maximizing Investigators’Research Award(No.R35GM119679);the National Institute of General Medical Sciences(No.R35GM144117);the support from the Professor Sylvan G.Frank Graduate Fellowship;the Presidential Fellowship.
Activated fibroblasts are major mediators of pulmonary fibrosis.Fibroblasts are generally found in the connective tissue but upon activation can generate excess extracellular matrix(ECM)in the lung interstitial sectio...
National Natural Science Foundation of China(Nos.22374116,22074118,82174088);Natural Science Basic Research Program of Shaanxi(2024JC-TBZC-21);Shaanxi Administration of Traditional Chinese Medicine(No.2022-SLRH-YQ-007)。
GPCRs are dominant targets for approved drugs and the discovery of lead compound targeting them is still challengeable.Affinity-based screening technique is a promising platform to uncover GPCR ligands.However,the int...
the Zhejiang Provincial Natural Science Foundation of China(No.LD22H310004);the“Pioneer”R&D program of Zhejiang,China(No.2022C03005);the National Natural Science Foundation of China(No.81770176,82204492);the Special Support Plan for Zhejiang Province High-Level Talents(China)(No.2019R52011).
Increasing evidence highlight tachykinin receptors as a prominent player in hematological malignancy.We previously revealed the proto-oncogenic role of neurokinin-1 receptor(NK-1R)in acute myeloid leukemia(AML),1 wher...
Science and Technology Key Project of Xuzhou Municipal Health Commission,Jiangsu Province,China(XWKYHT20210531);Pengcheng Yingcai-Medical Young Reserve Talent Programme(XWRCHT20220013).
Objective:To investigate whether angiotensinⅡtype 1 receptor(AGTR1 A1166C)gene polymorphism was associated with the effectiveness of valsartan monotherapy in Chinese patients with essential hypertension.Methods:This ...